InvestorsHub Logo
Followers 8
Posts 616
Boards Moderated 0
Alias Born 03/17/2011

Re: gi197845 post# 3115

Sunday, 05/22/2022 12:09:21 PM

Sunday, May 22, 2022 12:09:21 PM

Post# of 3197

Also, Nuplazid will be approve for Schizophrenia! We are going to win, for the benefit of the suffering patients and for our benefit as well!



There's a major unmet medical need here. Latest generation of anti-psychotics have devastating side effects and in most cases leave the pts much worse off, some times permanently.
if Nuplazid could help that subset of pts with hallucinations and delusions, it would be welcomed by pts, families and doctors.

I haven't looked at any trial results, so I have no idea whether this should or could happen any time soon.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACAD News